Support for S. 2029, the Grassley-Kohl Physician Payments Sunshine Act

Webp adobestock 299978300
Adobe Stock

Support for S. 2029, the Grassley-Kohl Physician Payments Sunshine Act

The following press release was published by the United States Senate Committee on Finance Chairman's News on July 16, 2008. It is reproduced in full below.

Support for S.2029, the Grassley-Kohl Physician Payments Sunshine Act

Introduction of the legislation in September 2007

June 10, 2008 New York Times editorial

April 16, 2008 Journal of the American Medical Association editorial

Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence

Catherine D. DeAngelis; Phil B. Fontanarosa JAMA 2008; 299: 1833-1835.

Letter of support from the American Medical Association for the Grassley-Kohl

Physician Payments Sunshine Act of 2007

Association of American Medical Colleges letter of endorsement

AdvaMed Endorsement Letter

Pharma Endorsement Letter

Letter from Abbott Lab Letter from Amgen Letter from AstraZeneca Letter from Baxter Letter from Boston Scientific Letter from Bristol Myers Squibb Eli Lilly letter of endorsement Letter from J&J Letter of endorsement from Medtronic, Inc.

Letter from Medtronic Merck Endorsement Letter Letter from Merck Letter from Pfizer Letter from St. Jude Medical Letter from Stryker Letter from Wyeth Letter from Zimmer Holdings Letter from Abbott

Source: US Senate Committee on Finance Chairman's News

More News